< Back to previous page
Researcher
Samir Kumar-Singh
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Infectious diseases, Anatomical pathology, Neurological and neuromuscular diseases, Clinical genetics and molecular diagnostics
Affiliations
- Laboratory of Medical Microbiology (LMM) (Research group)
Member
From1 Jan 2019 → Today - Laboratory of cell biology and histology (Research group)
Member
From1 Oct 2011 → Today - Translational Neurosciences (TNW) (Research group)
Member
From1 Oct 2011 → Today - Vaccine & Infectious Disease Institute (VAXINFECTIO) (Research group)
Member
From1 Oct 2011 → 31 Dec 2018 - Department of Biomedical Sciences - other (Research group)
Member
From1 Mar 2010 → 30 Sep 2011 - VIB CMN - Neurodegenerative Brain Diseases Group (Research group)
Member
From1 Oct 2003 → 28 Feb 2010
Projects
1 - 10 of 34
- Alliance for multidimensional and multidisciplinary neuroscience (µNEURO).From1 Jan 2026 → TodayFunding: BOF - research organisations
- Exploring the role of pathogen interactions in transitioning of ventilator-associated tracheobronchitis to pneumonia.From1 Jan 2025 → TodayFunding: FWO research project (including WEAVE projects)
- Impact of MPXV infection on pregnancy outcome and newborn health (PREGMPOX).From1 Aug 2024 → TodayFunding: Other European institutions (outside EU)
- Fecal microbiotal transplantation as a method for improving the outcomes of the dual radio- and immunotherapies within a colorectal cancer mouse model.From1 Oct 2022 → TodayFunding: SCK (Study Centre Nuclear Energy)
- Advanced Centre for Advanced Microscopy (ACAM).From1 Jan 2022 → TodayFunding: BOF - research organisations
- European Corona Vaccine Trial Accelerator Platform (VACCELERATE).From28 Jan 2021 → 27 Jan 2025Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- IMARK. Network for image-based biomarker discovery and evaluationFrom1 Jan 2021 → TodayFunding: IOF - mandates
- Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic (ORCHESTRA).From1 Dec 2020 → 30 Nov 2024Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic (ORCHESTRA).From1 Dec 2020 → 30 Nov 2024Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Molecular insights in SARS-CoV-2 pathogenesis and epidemiology.From1 Jun 2020 → 31 May 2021Funding: BOF - projects
Publications
31 - 40 of 94
- Biomarkers and molecular immunopathology of pneumonia(2022)Number of pages: 179
- Host immunity influences the composition of murine gut microbiota(2022)Published in: Frontiers in immunologyISSN: 1664-3224Volume: 13Pages: 1 - 15
- Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial(2022)Published in: The journal of antimicrobial chemotherapyISSN: 0305-7453Volume: 77Pages: 1862 - 1872
- No evidence for the involvement of leiomodin-1 antibodies in the pathogenesis of onchocerciasis-associated epilepsy(2021)Published in: PathogensISSN: 2076-0817Volume: 10
- The secretome of filarial nematodes and its role in host-parasite interactions and pathogenicity in onchocerciasis-associated epilepsy(2021)Published in: Frontiers in cellular and infection microbiologyISSN: 2235-2988Volume: 11
- Assessing the impact of flavophospholipol and virginiamycin supplementation on the broiler microbiota(2021)Published in: mSystemsISSN: 2379-5077Volume: 6
- A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severity(2021)Published in: JCI insightISSN: 2379-3708Volume: 6
- Neuropathological changes in Nakalanga syndrome: a case report(2021)Published in: PathogensISSN: 2076-0817Volume: 10
- Cytokines and onchocerciasis-associated epilepsy, a pilot study and review of the literature(2021)Published in: PathogensISSN: 2076-0817Volume: 10
- Serotonin levels in the serum of persons with onchocerciasis-associated epilepsy: a case-control study(2021)Published in: PathogensISSN: 2076-0817Volume: 10